Teruhiko Yokoyama Selected Research

Therapeutic Uses

3/2012

Botulinum toxin type A for the treatment of lower urinary tract disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teruhiko Yokoyama Research Topics

Disease

12	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2012 - 01/2004
9	Urinary Incontinence 03/2015 - 02/2004
8	Lower Urinary Tract Symptoms 01/2020 - 01/2004
6	Overactive Urinary Bladder (Overactive Bladder) 01/2020 - 01/2008
4	Prostatic Neoplasms (Prostate Cancer) 03/2012 - 01/2005
3	Ejaculatory Dysfunction 06/2015 - 10/2008
3	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2008 - 11/2003
2	Pain (Aches) 01/2020 - 01/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 03/2015 - 03/2012
2	Nocturia 12/2008 - 02/2004
2	Hypertrophy 12/2006 - 11/2003
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Cystitis 08/2021
1	Hypercholesterolemia 05/2014
1	Urinary Retention 05/2014
1	Underactive Urinary Bladder 05/2014
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2012
1	Multiple Sclerosis 03/2012
1	Residual Neoplasm 03/2012
1	Trigeminal Nerve Diseases (Trigeminal Nerve Disorders) 01/2012
1	Erectile Dysfunction 03/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2006
1	Neoplasms (Cancer) 01/2006
1	Disease Progression 10/2005
1	Urge Urinary Incontinence (Urge Incontinence) 08/2004
1	Stress Urinary Incontinence 08/2004
1	Diabetic Neuropathies (Diabetic Neuropathy) 09/2002
1	Diabetes Mellitus 09/2002

Drug/Important Bio-Agent (IBA)

5	Type A Botulinum Toxins (Botox)FDA Link 03/2015 - 08/2009
4	Pharmaceutical PreparationsIBA 08/2021 - 02/2004
3	Cholinergic Antagonists (Anticholinergics)IBA 03/2015 - 02/2004
3	NeurotoxinsIBA 01/2012 - 10/2007
2	mirabegronIBA 01/2020 - 10/2019
2	Solifenacin Succinate FDA Link 10/2019 - 01/2013
2	Muscarinic AntagonistsIBA 01/2013 - 01/2009
2	silodosin FDA Link 01/2012 - 10/2008
2	naftopidilIBA 01/2009 - 07/2006
2	loxoprofen (CS 600)IBA 12/2008 - 02/2004
2	Nerve Growth Factor (NGF)IBA 01/2008 - 09/2002
2	Hormones (Hormone)IBA 02/2006 - 02/2004
1	Tadalafil (Cialis)FDA Link 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014
1	imidafenacinIBA 01/2013
1	Therapeutic UsesIBA 03/2012
1	Cholinergic Agents (Cholinergics)IBA 03/2012
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2012
1	incobotulinumtoxinA FDA Link 01/2012
1	FM 4-64IBA 01/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2011
1	propiverineIBA 01/2009
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2006
1	Estramustine FDA Link 02/2006
1	Phosphates (Orthophosphate)IBA 02/2006
1	Ifosfamide FDA LinkGeneric 02/2006
1	Cisplatin (Platino)FDA LinkGeneric 02/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2005
1	SodiumIBA 02/2004
1	Hypnotics and Sedatives (Sedatives)IBA 02/2004
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 02/2004
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2004
1	urapidilIBA 01/2004
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2003
1	CalcineurinIBA 11/2003
1	Acetic Acid (Vinegar)FDA LinkGeneric 09/2002
1	Streptozocin (Streptozotocin)FDA Link 09/2002

Therapy/Procedure

9	Therapeutics 01/2020 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2004
2	Prostatectomy (Retropubic Prostatectomy) 01/2005 - 02/2004
1	Withholding Treatment 03/2015
1	Radiotherapy 03/2012
1	Brachytherapy 03/2012
1	Intradermal Injections 01/2012
1	Nephrectomy 10/2011
1	Combination Drug Therapy (Combination Chemotherapy) 02/2006
1	Transurethral Resection of Prostate (TURP) 06/2004
1	Aftercare (After-Treatment) 02/2004